Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit

NCT07561801 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07561801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07561801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2024
Completion date
June 1, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, contrast induced nephropathy, intensive care unit, pentoxifylline